Royce & Associates LP Increases Position in Owens & Minor, Inc. (NYSE:OMI)

Royce & Associates LP raised its holdings in shares of Owens & Minor, Inc. (NYSE:OMI - Free Report) by 179.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 80,914 shares of the company's stock after buying an additional 51,955 shares during the quarter. Royce & Associates LP owned about 0.10% of Owens & Minor worth $1,270,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Quarry LP grew its stake in shares of Owens & Minor by 290.1% in the second quarter. Quarry LP now owns 2,099 shares of the company's stock valued at $28,000 after buying an additional 1,561 shares in the last quarter. Innealta Capital LLC bought a new stake in Owens & Minor in the second quarter worth about $43,000. DekaBank Deutsche Girozentrale increased its holdings in Owens & Minor by 76.6% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company's stock worth $43,000 after acquiring an additional 1,356 shares during the period. Blue Trust Inc. lifted its position in Owens & Minor by 176.8% in the 3rd quarter. Blue Trust Inc. now owns 2,787 shares of the company's stock worth $44,000 after buying an additional 1,780 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its holdings in Owens & Minor by 100.6% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 6,071 shares of the company's stock worth $82,000 after buying an additional 3,044 shares during the period. 98.04% of the stock is owned by institutional investors.

Owens & Minor Stock Performance

Shares of NYSE OMI traded down $0.33 during mid-day trading on Wednesday, reaching $12.08. 123,916 shares of the company's stock were exchanged, compared to its average volume of 826,220. The firm has a 50-day moving average price of $13.92 and a two-hundred day moving average price of $15.30. The firm has a market capitalization of $931.49 million, a price-to-earnings ratio of -19.09, a price-to-earnings-growth ratio of 0.42 and a beta of 0.41. Owens & Minor, Inc. has a 52 week low of $11.42 and a 52 week high of $28.35. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45.

Owens & Minor (NYSE:OMI - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The business had revenue of $2.72 billion for the quarter, compared to analysts' expectations of $2.68 billion. During the same period in the prior year, the firm posted $0.44 EPS. The firm's quarterly revenue was up 5.0% on a year-over-year basis. Analysts predict that Owens & Minor, Inc. will post 1.49 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently commented on OMI shares. Barclays lowered their price objective on Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating on the stock in a research report on Tuesday, November 5th. UBS Group decreased their price objective on Owens & Minor from $28.00 to $25.00 and set a "buy" rating for the company in a report on Tuesday, November 5th. Robert W. Baird cut their target price on shares of Owens & Minor from $19.00 to $14.00 and set a "neutral" rating for the company in a report on Tuesday, November 5th. Citigroup cut their price objective on Owens & Minor from $21.00 to $18.50 and set a "buy" rating for the company in a research note on Tuesday, November 5th. Finally, StockNews.com lowered Owens & Minor from a "buy" rating to a "hold" rating in a report on Monday, August 26th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $18.50.

Owens & Minor Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.